Inhibitors & Agonists

You can also try the following methods, and our professionals will serve you Customized Consultation

Cat. No.	Product Name	Field of Application
DC11792	UMB-136	A novel bromodomain BRD4 inhibitor that significantly induces HIV-1 reactivation.
DC22507	SCH-00013	A novel cardiotonic agent that acts as a calcium sensitizer with no chronotropic activity in mammalian cardiac muscle, elicits positive inotropic effect in dog and rabbit ventricular muscles (EC50=9.2 uM).
DC11785	IHR-1	A novel cell membrane impermeable smoothened antagonist with IC50 of 7.6 nM in Hh-dependent Gli transcriptional activity assay.
DC11784	IHR-Nac	A novel cell permeable smoothened antagonist with IC50 of 3.1 nM in Hh-dependent Gli transcriptional activity assay.
DC22789	5S rRNA modificator 2	A novel chemical probe that enable selective 2’-hydroxyl acylation for accurate RNA structural analysis in living cells..
DC11628	HIV-1 Integrase Inhibitor 1	A novel compound that disrupts the HIV-1 integrase LEDGF interaction.
DC11521	Dotinurad Featured	Dotinurad is a novel compound that exhibits a remarkable uric acid excretion-promoting action.
DC20796	BIOD303	A novel conformational modulator of α-synuclein with EC50 of 105 uM, potentially outcompetes spermine in binding to α-synuclein.
DC8784	CTLA-4 inhibitor Featured	A novel CTLA-4 inhibitor.
DC22975	GB111-NH2 Featured	GB111-NH2 (Z-Phe-Lys-AOMK) is a novel cysteine cathepsin inhibitor that blocks the activity of cathepsins B, L and S. GB111-NH2 (Z-Phe-Lys-AOMK) inhibits autophagy and increases oxidative stress, specifically trigger macrophage cell death.
DC22648	VMY-1-103	A novel dansylated analog of purvalanol B, and a CDK inhibitor that inhibits cell cycle progression and proliferation in prostate and breast cancer cells more effectively than purvalanol B.
DC20927	CRS-3123	A novel diaryldiamine that inhibits bacterial methionyl-tRNA synthetases in Gram-positive bacteria as a novel agent to treat Clostridium difficile infection (CDI).
DC24099	CC-115 hydrochloride	A novel dual inhibitor of mTOR and DNA-PK with IC50 of 21 nM and 13 nM, respectively.
DC21412	SR-16157	A novel dual-acting steroid sulfatase inhibitor (IC50=0.1 uM) and selective ERα modulator (SERM).
DC10706	Ehp-inhibitor-2 Featured	A novel Ehp inhibitor
DC10705	Ehp-inhibitor-1 Featured	A novel Ehp inhibitor
DC22487	Benzenepentacarboxylic Acid Featured	Benzenepentacarboxylic acid is a fluorescent dye that detects and scavenge HO radicals.
DC22768	MP07-66 Featured	A novel FTY720 analog that acts as PP2A activator, disrupts the SET/PP2A interaction devoid of immunosuppressive effects leads to the reactivation of PP2A.
DC23458	AZD 9164	A novel highly potent, selective, long acting muscarinic receptor M3 antagonist with pIC50 of 9.8, 10-fold selectivity over M2 (pIC50=9.0).
DC22883	MK-7288	A novel histamine H3 receptor inverse agonist for the treatment of sleep apnoea syndrome.
DC24012	BI-224436	A novel HIV-1 non-catalytic-site integrase inhibitor (NCINI).
DC22944	NS-3623 Featured	A novel human RBC Cl-conductance blocker (IC50=210 nM) and HERG channel activitor (EC50=79.4 uM, HERG1 channel activation).
DC23936	IQ-R	A novel hypoxia-sensitive fluorescent probe.
DC22386	I-2906	A novel isocitrate lyase (ICL) inhibitor that displays showed excellent anti-Mycobacterium tuberculosisl activities and low cytotoxicity.
DC25013	ARM-1 Featured	A novel LTA4 hydrolase (LTA4H) inhibitor that inhibits LTB4 synthesis in human neutrophils with IC50 of 0.5 uM.
DC22856	ARN-5187	A novel lysosomotropic REV-ERB ligand that has a dual inhibitory activity toward REV-ERB-mediated transcriptional regulation and autophagy.
DC21378	Piromelatine	A novel melatonin melatonin receptor MT1/MT2 and serotonin 5-HT1A/5-HT1D receptor agonist.
DC11928	MPT0B002	A novel microtubule inhibitor, downregulates T315I mutant Bcr-Abl and induces apoptosis of imatinib-resistant chronic myeloid leukemia cells.
DC11935	PBOX-15	A novel microtubule targeting agent that induces apoptosis, upregulates death receptors, and potentiates TRAIL-mediated apoptosis in multiple cancer cells.
DC22773	DSR-71167	A novel mineralocorticoid receptor antagonist (IC50=0.26 uM) with carbonic anhydrase inhibitory activity (IC50=19 uM).

<Prev1...56 57 58 59 60...1297 Next>

Inhibitors & Agonists

Customized Consultation X

Your information is safe with us. * Required Fields.